Physicians May Fail to Recognize Symptoms of Toxicity in Breast Cancer Patients
The risk of underrecognition was higher when the physician was a man and the patient was younger or non-White.
The risk of underrecognition was higher when the physician was a man and the patient was younger or non-White.
Researchers sought to determine whether use of tumor match and adaptive RT improved incidence of adverse events and survival outcomes in patients with NSCLC.
Researchers sought to measure the risk of long-term neurocognitive outcomes in survivors of osteosarcoma and Ewing sarcoma.
The intervention also improved the rate of advance directive completion.
Cardiovascular disease-related warnings also took longer to be issued.